Clinical experience of switching from glargine or neutral protamine Hagedorn insulin to insulin detemir in type 2 diabetes: Observations from the Indian cohort in the A(1)chieve study

AIM: To explore the clinical safety and effectiveness of insulin detemir (IDet) in a subgroup of Indian patients with type 2 diabetes (T2D) switched from either insulin glargine (IGlar) or neutral protamine Hagedorn (NPH) insulin in the 24-week, non-interventional A(1)chieve study. MATERIALS AND MET...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wangnoo, Subhash Kumar, Ghosal, Samit, Akhtar, Shahid, Shetty, Raman, Tripathi, Sudhir
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Medknow Publications & Media Pvt Ltd 2014
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171898/
https://ncbi.nlm.nih.gov/pubmed/25285292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.139239
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak